Association between substantia nigra degeneration and functional outcome in patients with basal ganglia infarction

Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease

(2022) Koji Furukawa et al.   ANNALS OF NEUROLOGY

Delayed Infiltration of Peripheral Monocyte Contributes to Phagocytosis and Transneuronal Degeneration in Chronic Stroke

(2022) Keun Woo Park et al.   STROKE

Association of Substantia Nigra Degeneration with Poor Neurological Recovery in Basal Ganglia Infarctions

(2022) Kijeong Lee et al.   Journal of Stroke

Neurodegeneration of the Substantia Nigra after Ipsilateral Infarct: MRI R2* Mapping and Relationship to Clinical Outcome

(2019) Pierre Antoine Linck et al.   RADIOLOGY

Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke

(2018) Anne Ladwig et al.   Journal of Neuroimmune Pharmacology

Lenticulostriate Artery Involvement is Predictive of Poor Outcomes in Superficial Middle Cerebral Artery Territory Infarction

(2017) Kijeong Lee et al.   YONSEI MEDICAL JOURNAL

Predictive factors for decompressive hemicraniectomy in malignant middle cerebral artery infarction

(2016) Oliver von Olnhausen et al.   ACTA NEUROCHIRURGICA

La atorvastatina protege las neuronas GABAérgicas y dopaminérgicas del sistema nigroestriatal en un modelo experimental de isquemia cerebral focal transitoria en ratas

(2014) Angélica María Sabogal et al.   Biomedica

Secondary Neurodegeneration in Remote Regions After Focal Cerebral Infarction

(2012) Jian Zhang et al.   STROKE

Secondary Signal Change and an Apparent Diffusion Coefficient Decrease of the Substantia Nigra After Striatal Infarction

(2012) Makoto Nakajima et al.   STROKE

Signal Change of the Substantia Nigra on Diffusion-Weighted Imaging Following Striatal Infarction

(2010) Makoto Nakajima et al.   INTERNAL MEDICINE

What should be defined as good outcome in stroke trials; a modified Rankin score of 0–1 or 0–2?

(2008) N. Weisscher et al.   JOURNAL OF NEUROLOGY